KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Treasury Shares (2016 - 2025)

Idexx Laboratories has reported Treasury Shares over the past 17 years, most recently at $6.6 billion for Q4 2025.

  • Quarterly results put Treasury Shares at $6.6 billion for Q4 2025, up 23.01% from a year ago — trailing twelve months through Dec 2025 was $6.6 billion (up 23.01% YoY), and the annual figure for FY2025 was $6.6 billion, up 23.01%.
  • Treasury Shares for Q4 2025 was $2.4 million at Idexx Laboratories, up from $411000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for IDXX hit a ceiling of $27.9 million in Q2 2025 and a floor of $19000.0 in Q1 2023.
  • Median Treasury Shares over the past 5 years was $21.3 million (2021), compared with a mean of $13.3 million.
  • Biggest five-year swings in Treasury Shares: skyrocketed 32.3% in 2022 and later rose 1.88% in 2023.
  • Idexx Laboratories' Treasury Shares stood at $3.6 billion in 2021, then rose by 23.0% to $4.4 billion in 2022, then rose by 1.88% to $4.5 billion in 2023, then increased by 19.2% to $5.3 billion in 2024, then rose by 23.01% to $6.6 billion in 2025.
  • The last three reported values for Treasury Shares were $6.6 billion (Q4 2025), $6.3 billion (Q3 2025), and $6.1 billion (Q2 2025) per Business Quant data.